Hospital & Healthcare Management July 10, 2025

In this exclusive interview, HHM Global (Hospital& Healthcare Management) sits down with Laurent Van Lerberghe and David Buller, the Managing Partners of KELES, deeply engaged in ethical AI investments, particularly within the healthcare and pharmaceutical sectors. The conversation explores their insights into the role of ethical AI in business, challenges in transparency and accountability, compliance with evolving regulations, and how to effectively measure societal impact in AI-driven healthcare solutions.

____________________________________________________________________

HHM Global (Hospital & Healthcare Management):

Q. Ethical AI has become a widely discussed concept, especially in healthcare and pharmaceuticals. But when we speak specifically about ethical AI-driven businesses, how do you define them?

Laurent Van Lerberghe:

I’ll start here. Ethical AI, particularly in healthcare, is absolutely indispensable. We’ve worked...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Interview / Q&A, Technology, Trends
AI-enabled clinical data abstraction: a nurse’s perspective
Contextual AI launches Agent Composer to turn enterprise RAG into production-ready AI agents
OpenAI’s latest product lets you vibe code science
WISeR in 2026: Legal, Compliance, and AI Challenges That Could Reshape Prior Authorization for Skin Substitutes
Dario Amodei warns AI may cause ‘unusually painful’ disruption to jobs

Share Article